Robert C. Gallo

979 total citations
17 papers, 817 citations indexed

About

Robert C. Gallo is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, Robert C. Gallo has authored 17 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 7 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Robert C. Gallo's work include HIV Research and Treatment (8 papers), T-cell and Retrovirus Studies (5 papers) and Viral-associated cancers and disorders (4 papers). Robert C. Gallo is often cited by papers focused on HIV Research and Treatment (8 papers), T-cell and Retrovirus Studies (5 papers) and Viral-associated cancers and disorders (4 papers). Robert C. Gallo collaborates with scholars based in United States, Austria and Italy. Robert C. Gallo's co-authors include Paolo Lusso, Marvin S. Reitz, Carolyn A. Wilson, Marjorie Robert‐Guroff, Barbara Ensoli, Hsiao-Kuey Chang, H Romanczuk, J Finan, J.R. Selden and Beverly S. Emanuel and has published in prestigious journals such as Nature, Cell and JNCI Journal of the National Cancer Institute.

In The Last Decade

Robert C. Gallo

17 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert C. Gallo United States 13 348 290 246 232 220 17 817
R A Weiss United Kingdom 9 506 1.5× 475 1.6× 510 2.1× 335 1.4× 279 1.3× 12 1.3k
H.-G. Guo United States 10 508 1.5× 496 1.7× 544 2.2× 284 1.2× 123 0.6× 13 1.1k
Michael D. Moore United States 17 536 1.5× 288 1.0× 132 0.5× 453 2.0× 427 1.9× 22 1.2k
Gerold Feuer United States 19 209 0.6× 192 0.7× 244 1.0× 741 3.2× 191 0.9× 28 1.2k
Randy Fenrick United States 12 457 1.3× 144 0.5× 125 0.5× 226 1.0× 594 2.7× 16 1.1k
M Courcoul France 15 401 1.2× 155 0.5× 114 0.5× 362 1.6× 251 1.1× 26 952
Shamala Srinivas United States 10 189 0.5× 205 0.7× 121 0.5× 95 0.4× 251 1.1× 11 609
Takashi Odawara Japan 15 316 0.9× 109 0.4× 86 0.3× 210 0.9× 239 1.1× 46 704
C A Bohan United States 13 464 1.3× 174 0.6× 65 0.3× 315 1.4× 257 1.2× 14 762
Michelle Connole United States 14 275 0.8× 203 0.7× 109 0.4× 507 2.2× 219 1.0× 22 874

Countries citing papers authored by Robert C. Gallo

Since Specialization
Citations

This map shows the geographic impact of Robert C. Gallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Gallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Gallo more than expected).

Fields of papers citing papers by Robert C. Gallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Gallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Gallo. The network helps show where Robert C. Gallo may publish in the future.

Co-authorship network of co-authors of Robert C. Gallo

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Gallo. A scholar is included among the top collaborators of Robert C. Gallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Gallo. Robert C. Gallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Browning, Philip G. F., John Nicholas, Gary S. Hayward, et al.. (1997). Characterization of a Chemokine Receptor-Related Gene in Human Herpesvirus 8 and Its Expression in Kaposi's Sarcoma. Virology. 228(2). 371–378. 88 indexed citations
2.
Lisziewicz, Julianna, et al.. (1996). Efficacy of antitat Gene Therapy in the Presence of High Multiplicity Infection and Inflammatory Cytokines. Human Gene Therapy. 7(18). 2209–2216. 6 indexed citations
3.
Popescu, Nicholas C., et al.. (1996). Deletion and Translocation Involving Chromosome 3(p14) in Two Tumorigenic Kaposi's Sarcoma Cell Lines. JNCI Journal of the National Cancer Institute. 88(7). 450–455. 31 indexed citations
4.
Markham, Phillip D., et al.. (1996). Multiple Immunizations with Attenuated Poxvirus HIV Type 2 Recombinants and Subunit Boosts Required for Protection of Rhesus Macaques. AIDS Research and Human Retroviruses. 12(11). 985–992. 39 indexed citations
5.
Flamand, Louis, Robert A. Zeman, Joseph Bryant, Yanto Lunardi-Iskandar, & Robert C. Gallo. (1996). Rapid Communication: Absence of Human Herpesvirus 8 DNA Sequences in Neoplastic Kaposi's Sarcoma Cell Lines. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 13(2). 194–197. 37 indexed citations
6.
Chang, Hsiao-Kuey, Robert C. Gallo, & Barbara Ensoli. (1995). Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 tat protein. Journal of Biomedical Science. 2(3). 189–202. 77 indexed citations
7.
Lusso, Paolo & Robert C. Gallo. (1995). Human herpesvirus 6 in AIDS. Immunology Today. 16(2). 67–71. 111 indexed citations
8.
Benson, John M., Erwin Tschachler, Antoine Gessain, et al.. (1994). Cross-Neutralizing Antibodies against Cosmopolitan and Melanesian Strains of Human T Cell Leukemia/Lymphotropic Virus Type I in Sera from Inhabitants of Africa and the Solomon Islands. AIDS Research and Human Retroviruses. 10(1). 91–96. 24 indexed citations
9.
Barrett, N, Artur Mitterer, Wolfgang Mundt, et al.. (1989). Large-Scale Production and Purification of a Vaccinia Recombinant-Derived HIV-1 gp160 and Analysis of Its Immunogenicity. AIDS Research and Human Retroviruses. 5(2). 159–171. 48 indexed citations
10.
Bernard, Jacky, Brigitte Réveil, Isabelle Desportes, et al.. (1989). Persistent HIV-2 Infection of Rhesus Macaque, Baboon, and Mangabeys. Intervirology. 30(5). 258–267. 22 indexed citations
11.
Nerurkar, Lata S. & Robert C. Gallo. (1989). Human retroviruses: Cancer and aids. International Journal of Cancer. 44(S1). 2–5. 12 indexed citations
12.
Reitz, Marvin S., et al.. (1988). Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell. 54(1). 57–63. 161 indexed citations
13.
Saxinger, Carl, et al.. (1987). Stages in the Progression of HIV Infection in Chimpanzees. AIDS Research and Human Retroviruses. 3(4). 375–385. 9 indexed citations
14.
Gallo, Robert C.. (1987). Human Tumor and Immunodeficiency Viruses. AIDS Research and Human Retroviruses. 3(s1). 187–196. 8 indexed citations
15.
Gurgo, Corrado & Robert C. Gallo. (1987). Human Retroviruses: HTLV‐I, II, and III and Their Association with Leukemia and AIDS. Annals of the New York Academy of Sciences. 511(1). 350–369. 4 indexed citations
16.
Matthews, Thomas J., H. Kim Lyerly, Kent J. Weinhold, et al.. (1987). Prospects for Development of a Vaccine Against HTLV-III-Related Disorders. AIDS Research and Human Retroviruses. 3(s1). 197–206. 12 indexed citations
17.
Nowell̀, Peter C., J Finan, Riccardo Dalla Favera, et al.. (1983). Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line. Nature. 306(5942). 494–497. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026